MWE China’s Pharmaceuticals and Medical Products Practice Group provides fully integrated, multidisciplinary legal services to clients in a broad range of health, medical and biotechnology industries. Our lawyers regularly counsel clients on issues involving corporate transactions and finance, products regulation and reimbursement, legislative and government regulations, environmental regulation, food and agriculture, health regulatory, product liability, executive compensation, labor and employment, tax, anti-monopoly and antitrust, and international trade.
Our lawyers, patent agents and scientific advisors provide a full range of intellectual property prosecution and protection counsel required at each stage in the development of life sciences companies and their products. We understand the specific needs of pharmaceutical and medical-device companies and draw on the experience and knowledge of lawyers from throughout the firm to provide coordinated solutions that address short-term challenges while achieving long-term business goals.
Our clients include start-ups, mid-size companies and some of the world’s largest pharmaceutical and medical device companies. We also provide industry-focused advice to academic medical research centers, universities, investment banks and venture capital firms.
Among recent engagements, we represented one of the world’s largest and most comprehensive drug-development services companies in its strategic investment in China, counseling on issues including land use and real estate, foreign investment, corporate, tax and administrative law matters. We represented a US-listed company in its acquisition of all of the shares of a Chinese life sciences company, and one of the world’s leading blood-collection devices manufacturers in its dispute with a Chinese blood center and one of its distributors.